KUTRRH continues to champion impactful healthcare innovation as its CEO, Dr. Zeinab Gura, joined key stakeholders to share early findings from the Improving Oesophageal Cancer Survival in Kenya research project.This important dissemination forum highlighted the progress of a groundbreaking three‑year initiative funded by the National Institute for Health and Care Research (NIHR). The project aims to transform oesophageal cancer outcomes in Kenya through early detection, strengthened diagnostic capacity, and community-focused cancer awareness.
A Collaborative Effort to Improve Cancer Survival
The research project is being implemented collaboratively by KUTRRH and several leading local and international institutions, including:
- University of Manchester
- The Christie NHS Foundation Trust
- National Cancer Institute of Kenya (NCI‑Kenya)
Other project partners include:
- KEMRI (Kenya Medical Research Institute)
- KENCO (Kenya Network of Cancer Organizations)
- Kenyatta University
- Mount Kenya University
- Jomo Kenyatta University of Agriculture and Technology (JKUAT)
The project is built on a hub-and-spoke model, with KUTRRH serving as the national hub and five counties Meru, Nyeri, Kiambu, Nakuru, and Kisii acting as key implementation nodes. This structure strengthens county-level cancer services while enhancing referral pathways for timely diagnosis and treatment.
Three Strategic Pillars Guiding the Initiative
The oesophageal cancer research project focuses on three core pillars designed to address the major barriers affecting early detection and treatment in Kenya:
Community Engagement
- Increasing public awareness of oesophageal cancer symptoms
- Improving access to screening and cancer care services
- Strengthening referral and linkage-to-care pathways
Clinical Outcomes & Telemedicine
- Enhancing early diagnosis through clinician training
- Leveraging digital health tools for remote consultation and care coordination
- Collecting clinical data to improve treatment outcomes
Pathology & Early Detection
- Boosting diagnostic capacity in participating counties
- Advancing scientific understanding of oesophageal cancer biology in Kenya
- Standardising pathology processes to ensure faster, more accurate results
Recognising Progress and Encouraging Continued Collaboration
Speaking during the forum, Dr. Zeinab Gura applauded all partners for the significant milestones achieved so far. She emphasised the importance of sustaining awareness creation and strengthening linkages to care, noting that these efforts are essential to improving survival rates for oesophageal cancer patients.
Dr. Gura described the project as “a masterpiece of successful collaborative research,” highlighting its role in driving meaningful improvements in healthcare delivery. She encouraged all stakeholders to continue sharing findings widely—among communities, clinicians, researchers, and policymakers—to foster evidence-based decision-making and better patient outcomes.
Engaging Stakeholders Across Kenya and Beyond
The forum brought together project teams from KUTRRH, partner counties, and collaborating institutions. Virtual participation from UK-based project leads including Prof. Keith Brennan, Prof. Richard Cowan, Mercy Kibenda, and Dr. Dorothy Nyamai underscored the project’s global reach and multidisciplinary strength. Participants reviewed progress across the project’s objectives and discussed early findings that will inform the next phases of implementation.
A Major Step Toward Reducing the Burden of Oesophageal Cancer in Kenya
Oesophageal cancer remains one of Kenya’s most common and deadly cancers, often diagnosed late due to limited awareness and access to diagnostic services. This NIHR-funded initiative represents a major step toward reversing that trend by combining research, community outreach, capacity building, and clinical innovation. KUTRRH remains committed to collaborating with partners to advance cancer research and expand access to high-quality cancer care for all Kenyans.
